Print

CardioComm Solutions Inc. (CCG) Receives FDA Approval to Market the HeartCheck™ ECG Monitor as a Prescription Product  
8/29/2012 9:42:48 AM

TORONTO--(BUSINESS WIRE)--CardioComm Solutions, Inc. (TSX-V: EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of ECG acquisition and management software solutions, has received clearance from Health Canada for the sales and marketing of their Class II medical device for prescription based, hand-held ECG monitoring under the HeartCheck™ brand.
//-->